Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
52.29
+0.24 (+0.46%)
Streaming Delayed Price
Updated: 12:09 PM EDT, Oct 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,110,496
Open
52.67
Bid (Size)
52.28 (15)
Ask (Size)
52.29 (2)
Prev. Close
52.05
Today's Range
52.20 - 52.80
52wk Range
45.05 - 113.76
Shares Outstanding
N/A
Dividend Yield
4.20%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
1 Incredible Reason to Buy Novo Nordisk Stock (NVO) in November -- or Sooner
Today 6:20 EDT
It offers compelling weight-loss drugs -- and a compelling stock price, too.
Via
The Motley Fool
Novo Nordisk Shares Fell 5.6% After President Trump Commented on Future Price Cuts for Weight Loss Drugs. Should Investors Be Worried?
Today 5:45 EDT
It's not the end of the world for the drugmaker.
Via
The Motley Fool
Topics
Government
Intellectual Property
Performance
YTD
-40.3%
-40.3%
1 Month
-5.8%
-5.8%
3 Month
-3.1%
-3.1%
6 Month
-19.8%
-19.8%
1 Year
-53.5%
-53.5%
More News
Read More
If I Could Only Buy 2 Stocks in the Last Quarter of 2025, I'd Pick These
October 28, 2025
Via
The Motley Fool
Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers
October 27, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
P/E Ratio Insights for Novo Nordisk
October 24, 2025
Via
Benzinga
What Is 1 of the Best Pharmaceutical Stocks to Buy Now?
October 27, 2025
Via
The Motley Fool
Viking Therapeutics: High Risk, High Reward Play
October 27, 2025
Via
MarketBeat
Options Corner: A Reliable Quant Signal Just Flashed Again For Pharma Giant Novo Nordisk
October 23, 2025
Via
Benzinga
Eccogene Eyes Hong Kong IPO With Experimental Weight-Loss Drug, AstraZeneca Partnership
October 23, 2025
Via
Benzinga
Topics
Initial Public Offering
Breakout Momentum Plays You Need to Know About
October 23, 2025
Via
MarketBeat
Weight Loss Drugs Are Quietly Exploding Employer Health Insurance Costs: 'There Is A Quiet Alarm Bell Going Off'
October 23, 2025
Via
Benzinga
Marjorie Taylor Greene Buys 6 Stocks And Bitcoin ETF: Here's Her Latest Shopping List
October 22, 2025
Via
Benzinga
Novo Nordisk Shares Tumble Amid Sweeping Board Overhaul
October 22, 2025
Via
MarketMinute
Topics
Economy
Government
Intellectual Property
3 Things Investors Need to Know Ahead of Eli Lilly's Q3 Earnings Report
October 22, 2025
Via
The Motley Fool
Topics
Intellectual Property
These 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall
October 21, 2025
Via
The Motley Fool
Topics
Government
Did Eli Lilly Just Say "Checkmate" to Novo Nordisk?
October 21, 2025
Via
The Motley Fool
Behind the Scenes of Novo Nordisk's Latest Options Trends
October 20, 2025
Via
Benzinga
2 Beaten-Down Stocks to Buy and Hold for the Next Decade
October 20, 2025
Via
The Motley Fool
These 3 Obesity Drug Stocks Are Set to Soar This Fall and Beyond
October 20, 2025
Via
The Motley Fool
'No Place Is Risk-Free Until The World Is Polio-Free:' Bill Gates Urges Global Action To Close Deadly Immunity Gaps
October 19, 2025
Via
Benzinga
Benzinga Bulls And Bears: Stellantis, Papa John's, Oklo — And Trade Tensions Shake Chip Stocks
October 18, 2025
Via
Benzinga
Topics
World Trade
Trump's Weight-Loss Drug Push May Put These ETFs On A Diet
October 17, 2025
Via
Benzinga
Topics
ETFs
Government
Trump-Induced Volatility Aside, Novo Trades Cheap While Patents Protect Its Profits Until 2032
October 17, 2025
Via
Benzinga
Topics
Government
Intellectual Property
Novo Nordisk Stock Is Falling Friday: What's Driving The Action?
October 17, 2025
Via
Benzinga
Trump Pledges To Cut Obesity Drug Prices. Novo Nordisk, Eli Lilly Stocks Dive.
October 17, 2025
Via
Investor's Business Daily
Topics
Government
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 52.29
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 10/29/25 12:09 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.